Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.24.1.u1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
Revenues $ 0 $ 0
Operating expenses 688,000 765,000
Research and development expenses 203,000 486,000
Loss from operations (891,000) (1,251,000)
PPP loan debt forgiveness 0 63,000
Interest and financing expense (333,000) (360,000)
Net Loss $ (1,224,000) $ (1,548,000)
Net loss per common share, basic $ (0.00) $ (0.00)
Net loss per common share, diluted $ (0.00) $ (0.00)
Weighted average common shares outstanding, basic 385,561,786 361,790,243
Weighted average common shares outstanding, diluted 385,561,786 361,790,243